• Home
  • Search Results
  • Non-isotopic dual parameter competition assay suitable for high-throughput screening of histone deacetylases.

Non-isotopic dual parameter competition assay suitable for high-throughput screening of histone deacetylases.

Bioorganic & medicinal chemistry letters (2009-05-22)
Daniel Riester, Christian Hildmann, Patricia Haus, Antonia Galetovic, Andreas Schober, Andreas Schwienhorst, Franz-Josef Meyer-Almes
ABSTRACT

Histone deacetylases reside among the most important and novel target classes in oncology. Selective lead structures are intensively developed to improve efficacy and reduce adverse effects. The common assays used so far to identify new lead structures suffer from many false positive hits due to auto-fluorescence of compounds or triggering undesired signal transduction pathways. These drawbacks are eliminated by the dual parameter competition assay reported in this study. The assay involves a new fluorescent inhibitor probe that shows an increase in both, fluorescence anisotropy and fluorescence lifetime upon binding to the enzyme. The assay is well suited for high-throughput screening.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
7-Amino-4-methylcoumarin, 99%
Sigma-Aldrich
7-Amino-4-methylcoumarin, Chromophore for substrates
Sigma-Aldrich
Atto 700 NHS-ester, BioReagent, suitable for fluorescence, ≥90% (coupling to amines)
Sigma-Aldrich
Atto 700 azide, suitable for fluorescence
Sigma-Aldrich
Atto 700 maleimide, BioReagent, suitable for fluorescence, ≥90% (coupling to thiols)
Sigma-Aldrich
Atto 700, BioReagent, suitable for fluorescence, ≥96.0% (HPCE)

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.